Diltiazem

Founded when Xu Jiuzhen leased a factory in 2007 to launch the Aladdin reagent brand, Shanghai Aladdin Biochemical Technology Co., Ltd. was formally incorporated in 2009 and has grown into a listed company on the Shanghai Stock Exchange's STAR Market (stock code 688179) since 2020. The manufacturer produces active pharmaceutical ingredients, bio products, finished dosage forms, pharmaceutical excipients, and pharmaceutical intermediates, and has expanded internationally through subsidiaries in the United States, Singapore, Ireland, and Germany, alongside a series of domestic acquisitions expanding its biochemical reagent, recombinant protein, and protein detection product lines, including stakes in Shanghai Yuanye Bio-Technology, Shanghai Yaozong Bio-Technology, and Shanghai Youke Instrument, and a joint venture with Guangdong Feipeng Biotechnology entering the IVD diagnostics field. The company operates a dedicated GMP manufacturing facility and a Zhangjiang biological R&D center, and serves markets across North America, Latin America, Europe, Australasia, Asia, the Middle East, and Africa, emphasizing brand recognition, international certification, an experienced R&D team, delivery speed, production capacity, and a broad product line.